Enzymatica develops solutions that support the body's own defenses against virus, irritants and microorganisms.
the science that protects
articles & insights
October 11, 2023
ColdZyme reduces rhinovirus viral load and sore throat symptoms according to new study
September 11, 2023
Interview with Professor Doris Wilflingseder about how ColdZyme breaks the viral infection cycle
August 24, 2023
Positive results from new study on influenza - CEO Claus Egstrand interviewed by BioStock
press releases
November 30, 2023 - Regulatory press release
November 7, 2023 - Regulatory press release
September 21, 2023 - Regulatory press release
financial reports
enzyme science
Research has shown that in some cold-adapted marine organisms such as cod there is an enzyme with good protective properties.
research& development
Enzymatica focuses on product development based on the tested and patented barrier technology used in the common cold product ColdZyme.
sustainability
Health and well-being constitute the foundation of our company, and we want to use resources wisely and sustainably.